| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Ulefnersen | ION-363 | Phase 3 Clinical | Ionis Pharmaceuticals Inc | Amyotrophic Lateral Sclerosis | Details |
| RAG-21 | RAG-21 | Phase 1 Clinical | Ractigen Therapeutics (Nantong) Co Ltd | Amyotrophic Lateral Sclerosis | Details |